AVORIE KENNARD: Open Payments
NPI 1245904333 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 11 payments from 7 companies in 2025. Trend: 2023 $1,246 · 2024 $1,402 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $121 |
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| Paratek Pharmaceuticals, Inc. | 1 | $54 |
| Novo Nordisk Inc | 2 | $39 |
| Exact Sciences Corporation | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $15 |
Products named: GATTEX, NUZYRA, AIRSUPRA, Cologuard Collection Kit, BREZTRI, Ozempic, KEVEYIS, FARXIGA.
Industry payments across TX — which companies pay providers there.
